Posted on 23 December 2009. Tags: critical, deal flow, disease, friends, grant-proposals, mosquito nets, other-words, profile, public, see-scores, words
As a family foundation, we get a whole lot of deal flow (a phrase I’ve learned from my friends in the investment community) – in other words we see scores of incredible (and some times not so incredible) grant proposals and social … Malaria No More works to raise the profile of the disease among the public, policymakers, and businesses , while engaging the private sector to provide life-saving mosquito nets and other critical interventions to families in Africa. …
Here is the original post:
Great nonprofits that should make your holiday list
Posted in Investing In Private Businesses
Posted on 19 November 2009. Tags: all-diabetes, Alzheimer, centers, disease, disease-control, last-few, people-aged, Retirement News, the-disease
When it comes to Alzheimer’s disease, the good news is that the last few decades have seen an explosion in fundamental scientific knowledge about what causes Alzheimer’s and what happens as the disease progresses. … Diabetes can affect many people in independent living communities and other retirement communities, since approximately half of all diabetes cases are diagnosed in people aged 60 or older, according to the Centers for Disease Control and Prevention. …
See more here:
The Outlook for Alzheimer's
Posted in Retirement News
Posted on 03 November 2009. Tags: creative-short, disease, down-payment, estate, estate-investing, important, older-cars, Real Estate Investing, real-estate, tips-on-flipping
Creative Real Estate Investing . tips on flipping real estate with no down payment, creative short sales and more! home · archives · about. ← Why is it Important to Stop Gum Disease? Taking care of older cars → …
Go here to read the rest:
Bathroom remodeling and the things that one needs to upgrade …
Posted in Real Estate Investing
Posted on 06 October 2009. Tags: Alternative Investing, despite-some, disease, from-ongoing, liver toxicity, news-yesterday, oncologic, oncologic-drugs, panel, Votrient
GlaxoSmithKline ( GSK ) received positive news yesterday when the US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in favor of the company’s experimental kidney cancer drug, Votrient (pazopanib). Importantly, the panel voted that Votrient can benefit patients by slowing the disease, despite some risk of liver damage. We believe the company may be asked to submit data from ongoing studies to ensure that liver toxicity associated with the use o
Read more:
FDA Panel Backs Glaxo’s Votrient – Analyst Blog
Posted in Alternative Investing